Conserved type III secretion system exerts important roles in Chlamydia trachomatis
- PMID: 25337183
- PMCID: PMC4203154
Conserved type III secretion system exerts important roles in Chlamydia trachomatis
Abstract
Upon infection, Chlamydiae alter host cellular functions in a variety of ways. Chlamydial infection prevents host cell apoptosis, induces re-organization of the actin cytoskeleton and alters host cellular signaling mechanisms. Chlamydia is among the many pathogenic Gram-negative bacteria that employ the type III secretion system (T3SS) to overcome host defenses and exploit available resources. T3SS are used by many Gram-negative bacterial pathogens to manipulate eukaryotic host cells through the delivery of effector proteins into their cytosol and membranes. T3SS is an evolutionarily refined, virulence determinant of Gram-negative bacteria where more than 20 proteins form an apparatus, generally termed injectisome, to achieve the vectorial secretion and translocation of anti-host effector proteins. This review describes challenges and recent advances that have revealed how Chlamydia trachomatis utilizes diversification to produce a conserved T3SS that exerts an important role in Chlamydia trachomatis.
Keywords: Chlamydia trachomatis; chaperones; effectors; injectisomes; regulators; type III secretion system.
Figures
Similar articles
-
Context-Dependent Action of Scc4 Reinforces Control of the Type III Secretion System.J Bacteriol. 2020 Jul 9;202(15):e00132-20. doi: 10.1128/JB.00132-20. Print 2020 Jul 9. J Bacteriol. 2020. PMID: 32424009 Free PMC article.
-
Type III Secretion in Chlamydia.Microbiol Mol Biol Rev. 2023 Sep 26;87(3):e0003423. doi: 10.1128/mmbr.00034-23. Epub 2023 Jun 26. Microbiol Mol Biol Rev. 2023. PMID: 37358451 Free PMC article. Review.
-
Chlamydia trachomatis Slc1 is a type III secretion chaperone that enhances the translocation of its invasion effector substrate TARP.Mol Microbiol. 2011 Oct;82(1):131-44. doi: 10.1111/j.1365-2958.2011.07802.x. Epub 2011 Sep 2. Mol Microbiol. 2011. PMID: 21883523 Free PMC article.
-
New frontiers in type III secretion biology: the Chlamydia perspective.Infect Immun. 2014 Jan;82(1):2-9. doi: 10.1128/IAI.00917-13. Epub 2013 Oct 14. Infect Immun. 2014. PMID: 24126521 Free PMC article. Review.
-
Got mutants? How advances in chlamydial genetics have furthered the study of effector proteins.Pathog Dis. 2021 Feb 4;79(2):ftaa078. doi: 10.1093/femspd/ftaa078. Pathog Dis. 2021. PMID: 33512479 Free PMC article. Review.
Cited by
-
Natural Product Type III Secretion System Inhibitors.Antibiotics (Basel). 2019 Sep 24;8(4):162. doi: 10.3390/antibiotics8040162. Antibiotics (Basel). 2019. PMID: 31554164 Free PMC article. Review.
-
A 2-pyridone amide inhibitor of transcriptional activity in Chlamydia trachomatis.Antimicrob Agents Chemother. 2023 May 1;95(5):e01826-20. doi: 10.1128/AAC.01826-20. Epub 2021 Feb 16. Antimicrob Agents Chemother. 2023. PMID: 33593835 Free PMC article.
-
Chlamydia cell biology and pathogenesis.Nat Rev Microbiol. 2016 Jun;14(6):385-400. doi: 10.1038/nrmicro.2016.30. Epub 2016 Apr 25. Nat Rev Microbiol. 2016. PMID: 27108705 Free PMC article. Review.
-
Chlamydia trachomatis and Chlamydia pneumoniae Interaction with the Host: Latest Advances and Future Prospective.Microorganisms. 2019 May 16;7(5):140. doi: 10.3390/microorganisms7050140. Microorganisms. 2019. PMID: 31100923 Free PMC article. Review.
-
Pyocyanin Inhibits Chlamydia Infection by Disabling Infectivity of the Elementary Body and Disrupting Intracellular Growth.Antimicrob Agents Chemother. 2018 May 25;62(6):e02260-17. doi: 10.1128/AAC.02260-17. Print 2018 Jun. Antimicrob Agents Chemother. 2018. PMID: 29610203 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical